|
J Biol Chem, Vol. 273, Issue 13, 7488-7494, March 27, 1998
Hetero-oligomerization-dependent Binding of Pig
Oocyte Zona Pellucida Glycoproteins ZPB and ZPC to Boar Sperm
Membrane Vesicles*
Edward C.
Yurewicz §,
Anthony G.
Sacco ,
Satish K.
Gupta¶,
Naxing
Xu , and
Douglas A.
Gage
From the Department of Obstetrics & Gynecology, Wayne
State University, Detroit, Michigan 48201, the ¶ Gamete Antigen
Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New
Delhi, India, and the Department of Biochemistry, Michigan State
University, East Lansing, Michigan 48824
 |
ABSTRACT |
The zona pellucida surrounding the pig oocyte
contains two Mr 55,000 glycoproteins, pZPB and
pZPC, which are orthologues of mouse zona proteins ZP1 and ZP3,
respectively. We previously reported that isolated boar sperm membrane
vesicles possess high affinity binding sites for partially purified
pZPB, but not pZPC. Interestingly, co-incubation experiments also
implicated pZPB-pZPC complexes as potential ligands. We now report that
when depleted of a minor pZPC contaminant by size exclusion
chromatography, pZPB lacks independent binding activity. In solid phase
binding assays employing immobilized boar sperm membranes, pZPB failed
to compete with biotin-(pZPB+pZPC) probe, and biotin-labeled pZPB
yielded negligible binding. However, when co-incubated with pZPC prior
to the binding assays, pZPB acted as a potent competitor, and
biotin-labeled pZPB exhibited high affinity, saturable binding. Binding
activity was attributed to pZPB-pZPC heterocomplexes, which were
detected in co-incubation mixtures by size exclusion chromatography and Western blot analysis. In the pig, therefore, sperm membranes possess a
zona-binding protein with high affinity sites for pZPB-pZPC heterocomplexes, but not free glycoprotein subunits. Consequently, associative interactions between zona molecules can contribute toward
both the assembly of the zona matrix and generation of ligands
important for sperm-zona interactions.
 |
INTRODUCTION |
The zona pellucida is a morphologically discrete, extracellular
matrix which envelops and protects the oocyte and preimplantation embryo. This egg investment also actively participates in the fertilization process. The zona pellucida provides docking sites for
species-specific sperm attachment and induces bound sperm to undergo
the acrosome reaction, the preparatory event for zona penetration and
eventual sperm-egg fusion. This intimate association of male and female
gametes is mediated in part by sperm-adhesive glycoproteins within the
zona matrix and complimentary zona-binding proteins on the sperm
surface. Interestingly, although multiple gamete adhesion molecules
have been characterized at the molecular level (1-11), the relative
physiological importance of many remains a topic of considerable debate
(12).
Zonae pellucidae contain a repertoire of glycoproteins encoded by three
gene families that are conserved across species. Adopting the
terminology of Harris et al. (13), the three
cDNA-predicted precursor polypeptides in the pig (10, 13, 14) are
herein designated pZPA (79 kDa), pZPB (59 kDa), and pZPC (46 kDa). Due to post-translational processing, the three mature glycoproteins from
isolated zonae appear on nonreducing SDS gels as two diffuse bands
(15); pZPA runs at Mr 90,000, whereas pZPB and
pZPC co-migrate at Mr 55,000. Electrophoretic or
chromatographic protocols permit isolation of co-purified pZPB and pZPC
glycoproteins (15-17) and such pZP(B+C) preparations exhibit several
important biological activities, including: stimulation of the acrosome
reaction in capacitated boar sperm (18), inhibition of sperm-zona
attachment (19, 20), binding to a sulfated polysaccharide-binding
domain on boar sperm proacrosin (21), and binding to isolated boar sperm membrane vesicles (22).
Although intractable to further purification as fully glycosylated
entities, pZPB and pZPC elute as separate peaks during reverse phase
HPLC1 when pretreated with
endo- -galactosidase (17). The pZPC glycoprotein (Mr 41,000 following endo- -galactosidase
digestion) elutes first and appears homogeneous on SDS gels. The pZPB
glycoprotein (Mr 44,000 following
endo- -galactosidase digestion) follows and routinely contains small
amounts (5-10%) of pZPC contaminant.
Purified pZPB and pZPC differ markedly in apparent biological activity.
When tested in gamete adhesion assays, pZPB inhibits sperm-zona
binding, whereas pZPC is without effect (20, 23). Likewise, when tested
in solid phase binding assays, biotin-labeled pZPB binds to immobilized
boar sperm membranes in a concentration-dependent, saturable manner, whereas biotin-pZPC does not (22). In competition assays, pZPB blocks binding of a biotin-pZP(B+C) probe to membranes; pZPC fails to compete but, surprisingly, enhances the apparent affinity
of pZPB for its cognate zona-binding protein. Collectively, the data
suggest that (i) boar sperm possess a zona-binding protein with a
pZPB-binding domain that recognizes both pZPB and putative pZPB-pZPC
complexes, and (ii) interaction of pZPB with pZPC enhances pZPB
binding affinity.
More recently, both pZPB- and pZPC-specific antibodies were
unexpectedly found to block binding of biotin-pZPB to boar sperm membranes.2 This paradoxical
data prompted us to question whether the pZPB glycoprotein indeed binds
independently to membrane-associated zona-binding proteins. Could minor
amounts of putative pZPB-pZPC complexes account for the observed
binding activity of our previous pZPB preparations? Here we
conclusively demonstrate that whereas pZPC and more highly purified
pZPB lack independent binding activity, reconstituted pZPB-pZPC
heterocomplexes are novel, high affinity ligands for zona-binding
molecules present in boar sperm membrane vesicles.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Three different pig zona protein preparations
were used in this study. Their nomenclature conforms with that adapted
by Harris et al. (13). pZP(B+C) was purified from
heat-solubilized porcine zonae by gel filtration and hydroxyapatite
chromatography and consists of fully glycosylated pZPB and pZPC
glycoproteins (17). pZPB and pZPC were isolated from
endo- -galactosidase-digested pZP(B+C) by reverse phase HPLC (17).
pZP(B+C), pZPB, and pZPC correspond to preparations designated ZP3,
ZP3 , and ZP3 in prior publications from this laboratory. Membrane
vesicles were isolated from capacitated boar sperm by nitrogen
cavitation and differential centrifugation and stored at 70 °C as
described previously (22).
Antibodies--
The rabbit polyclonal antiserum raised against
the keyhole limpet hemocyanin-conjugated peptide CELQIAKDERYGS
(residues 319-330 of the deduced pZPB precursor protein with an added
N-terminal cysteine) was described previously (24). Affinity
purification on a matrix consisting of the synthetic peptide coupled to
AminoLink resin (Pierce) yielded pZPB-specific, site-directed
antibodies (anti-pZPB319-330). For pZPC-specific
immunodetection, we used an ascites fluid containing a previously
described (25) mouse monoclonal antibody, MA-451, which recognizes an
internal pZPC epitope (EEKLVF, residues 166-171 of cDNA-derived
pZPC precursor protein) (26). Horseradish peroxidase-conjugated
secondary antibodies were obtained from Amersham.
Size-exclusion Chromatography--
HPLC separations were
performed on a Dionex instrument equipped with a TSK
G3000SWXL column (7.8 × 300 mm, TosoHaas). The flow
of high-salt PBS (50 mM sodium phosphate, pH 6.6, 300 mM NaCl) was maintained at 0.5 ml/min at ambient
temperature. For preparative isolations, lyophilized proteins were
reconstituted in high-salt PBS and centrifuged through Spin-X filter
units (0.45-µm cellulose acetate, Costar) prior to injection.
Individual peaks were collected manually, pooled from multiple runs,
concentrated by ultrafiltration (Centricon-10, Amicon) to a final
protein concentration of >500 µg/ml, and stored at 20 °C. The
TSK G3000SWXL column was calibrated daily using blue
dextran 2000 and dinitrophenyl-glycine as void volume
(Vo) and total volume (Vt)
markers, respectively. The elution position (Ve) of
individual peaks was used to calculate Kav using
the equation, Kav = (Ve Vo)/(Vt Vo).
Mass Spectrometry--
MALDI-MS of zona proteins was performed
on a PerSeptive Biosystems Voyager Elite instrument equipped with a
nitrogen laser emitting at 337 nm with a pulse duration of 2 ns. The
instrument was operated at an accelerating voltage of 30 KV in the
linear continuous extraction mode. Sinapinic acid
(3,5-dimethoxy-4-hydroxycinnamic acid) was used as the MALDI matrix and
dissolved in acetonitrile/water/trifluoroacetic acid (50:49.9:0.1,
v/v/v) to make a solution of 10 mg/ml. Proteins were dialyzed against
25 mM ammonium acetate and lyophilized to dryness prior to
analysis. To prepare the target, 1 µl of the protein sample dissolved
in water was mixed with 1 µl of matrix solution on the sample plate
cell and air-dried.
Immunoblotting--
Zona proteins were separated by SDS-gel
electrophoresis on nonreducing 10% polyacrylamide gels and transferred
to nitrocellulose (Novex). After treatment with BlockerTMBLOTTO
(Pierce), membranes were incubated with either 0.5 µg/ml
anti-pZPB319-330 or MA-451 diluted 1:5000. Bound
antibodies were decorated with horseradish peroxidase-conjugated second
antibodies diluted 1:5000 and visualized with ECL reagents and
Hyperfilm-ECL (Amersham).
Solid Phase Binding Assays--
Interactions between purified
zona proteins and boar sperm membrane vesicles were investigated using
a previously described solid phase binding assay (22) with minor
modifications. Immulon-2 microtiter wells (Dynatech) were coated with
500 ng of sperm membranes and subsequently blocked with 1% BSA. For
competition binding assays, wells were incubated in quadruplicate with
50 µl of 0.2 µg/ml biotin-pZP(B+C) in TBS/T/BSA (20 mM
Tris, pH 8.0, 150 mM NaCl, 0.02% sodium azide, 0.05%
Tween 20, 0.1% BSA) in the presence and absence of unlabeled
competitor. Competitors were preincubated overnight at 4 °C in
high-salt PBS, diluted in TBS/T/BSA to twice their final concentration,
and mixed with an equal volume of 0.4 µg/ml biotin-pZP(B+C) at least
30 min prior to transfer to wells. Binding of biotin-labeled probe was
measured using strepavidin-alkaline phosphatase (Jackson
ImmunoResearch) and p-nitrophenyl phosphate. Absorbance
values at 405 nm were recorded using a Bio-Tek microplate reader. All
data in competition assays were corrected for nonspecific binding as
determined in wells incubated with biotin probe in the presence of a
100-fold excess of pZP(B+C). IC50 (mean ± S.E.) values are defined as the concentration of competitor required to
inhibit binding of biotin-pZP(B+C) by 50%; for co-incubates, IC50 values represent the concentration of the pZPB
component only.
Direct binding assays followed a similar protocol, except that
biotin-labeled proteins were preincubated overnight at 4 °C at 50
µg/ml, either alone or with added test protein, in high-salt PBS and
then diluted into replicate tubes, one containing TBS/T/BSA (total
binding) and the other TBS/T/BSA plus a 100-fold excess of pZP(B+C)
relative to the biotin-labeled ligand (nonspecific binding). Wells were
incubated in triplicate. EC50 values (mean ± S.E.)
were calculated by nonlinear regression analysis of saturation binding
data using the one-site binding equation in PRISM software (GraphPad).
Miscellaneous--
For biotin labeling, 450 µg of protein was
reacted with 30 µg of D-biotinoyl- -aminocaproic
acid-N-hydroxysuccinimide ester in 180 µl of 50 mM sodium borate buffer, pH 8.0. After a 1-h incubation at
ambient temperature, the reaction was quenched with ammonium chloride.
Biotinylated protein was recovered by HPLC on a TSK G3000SWXL column in high-salt PBS and concentrated by
ultrafiltration. Proteins were quantitated using a BCA Protein Assay
kit (Pierce) in a microtiter plate format. BSA was used to construct
standard curves. Protein concentrations were converted to molarities
using molecular masses of 36,670 and 36,308 Da for the core
polypeptides of pZPB (cDNA-deduced residues 137-446) and pZPC
(cDNA-deduced residues 23-348), respectively; N termini have been
experimentally determined (17, 27) and C termini are positioned at
consensus sites for furin cleavage (10, 13).
 |
RESULTS |
Purification of pZPB Glycoprotein by Size Exclusion
Chromatography--
To produce a preparation depleted of residual
pZPC, we subjected pZPB to size exclusion chromatography on a TSK
G3000SWXL column in high-salt PBS. Under these conditions,
pZPB eluted as a series of incompletely resolved UV peaks (Fig.
1A). The first peak emerged in
the column void volume (exclusion limit >700 kDa) and the final peak
eluted between the 43- and 80-kDa molecular mass markers. Five
subfractions, designated pZPB1-pZPB5 and
containing 15, 17, 21, 21, and 26% of recovered protein, respectively,
were collected (Fig. 1A) and concentrated by
ultrafiltration. Macromolecular compositions were examined by
SDS-polyacrylamide gel electrophoresis and immunoblotting. Protein
staining revealed the pZPB glycoprotein as a predominant
Mr 44,000 band ( 95% of total Coomassie Blue staining) in the pZPB preparation used as starting material (Fig. 1B, lane B) and in each pZPB subfraction obtained
by size exclusion chromatography (Fig. 1B, lanes
1-5). By comparison, purified pZPC glycoprotein migrates as a
Mr 41,000 band (Fig. 1B, lane
C). Subfractions pZPB1-pZPB3 also
contained a Mr 81,000 band accounting for <5% of total Coomassie Blue staining.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 1.
Purification of pZPB by size exclusion
chromatography. A, elution profile on TSK
G3000SWXL resin. 200 µg of pZPB in 100 µl of high-salt
PBS was injected onto the TSK G3000SWXL column running at
0.5 ml/min in high-salt PBS mobile phase. Five subfractions (pZPB1-pZPB5) were collected as indicated.
Arrowheads mark the elution positions of the protein
standards, thyroglobulin (669 kDa), glutamate dehydrogenase (330 kDa),
IgG (160 kDa), transferrin (80 kDa), and ovalbumin (43 kDa).
B, Coomassie Blue staining of proteins (1 µg/lane)
separated on a 10% NuPAGE gel (Novex) in MES/SDS running buffer.
Lane B, pZPB starting material; lanes 1-5,
subfractions pZPB1-pZPB5; lane C,
pZPC. Mr values are indicated on the
right. C, Western blots of subfractions
pZPB1-pZPB5 (lanes 1-5) separated
on 10% SDS gels in Tris glycine/SDS running buffer. Wells were loaded
with 40 ng of protein for pZPB-specific immunostaining with
anti-pZPB319-330 polyclonal antibody or 200 ng of protein for pZPC-specific immunostaining with MA-451 monoclonal antibody. Note
the minimal signal for pZPC bands in subfractions pZPB4 and pZPB5.
|
|
Western blots were probed with anti-pZPB319-330 and MA-451
to visualize pZPB and pZPC glycoproteins, respectively. Immunostaining with anti-pZPB319-330 uniformly illuminated the
Mr 44,000 pZPB glycoprotein in all five
subfractions (Fig. 1C, top). In contrast, MA-451
produced dramatically different staining intensities of pZPC bands in
subfractions pZPB1-pZPB3 versus
pZPB4-pZPB5 (Fig. 1C,
bottom). Subfractions pZPB1-pZPB3
possessed easily detected Mr 41,000 and 81,000 pZPC bands; the Mr 81,000 band was not visible on reducing gels and presumably represents a disulfide-bonded dimer of
pZPC. Importantly, subfractions pZPB4 and pZPB5
yielded barely discernible pZPC bands, thus indicating negligible pZPC cross-contamination.
Competitive Binding Activity of pZPB Subfractions--
To assess
relative ligand activity of pZPB subfractions toward boar sperm
zona-binding proteins, we constructed competitive binding curves using
immobilized membrane vesicles as the source of zona-binding proteins
and biotin-pZP(B+C) as labeled probe. Significantly, only those
subfractions possessing both pZPB and pZPC glycoproteins demonstrated
competitor activity (Fig. 2A). Subfractions pZPB1-pZPB3 blocked binding of
biotin-pZP(B+C) to immobilized membranes with respective
IC50 values (n = 2) of 20.7 ± 7.1, 36.0 ± 4.9, and 103 ± 22 nM. In striking
contrast, pZPB4 and pZPB5 did not compete
(IC50 > 1 µM) with the biotin-pZP(B+C) probe.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
Competitive inhibition of biotin-pZP(B+C)
binding to boar sperm membrane vesicles by pZPB subfractions.
Microtiter plate wells were coated with 500 ng of boar sperm membrane
vesicles and challenged with 0.2 µg/ml biotin-pZP(B+C) probe in the
presence or absence of competing pZPB subfractions that had been
preincubated (overnight, 4 °C) at 400 µg/ml in high-salt PBS. All
data are corrected for nonspecific binding as determined from wells
incubated with biotin-pZP(B+C) in the presence of a 100-fold excess of
unlabeled pZP(B+C) competitor. A, competition curves
obtained using subfractions pZPB1-pZPB5. Note
that subfractions pZPB4 and pZPB5, which are devoid of appreciable pZPC in immunoblot assays, do not compete. B, competitor activity of subfraction pZPB5
following overnight co-incubation with varying amounts of pZPC. The
IC50 values were determined from competition binding curves
for co-incubates with pZPC: pZPB5 ratios between 0.05:1 and
1:1 (w/w). C, competition curves obtained with pZPC alone
and subfractions pZPB1-pZPB5 after overnight
co-incubation with pZPC (pZPC:pZPB = 0.5:1). In contrast to
disparate IC50 values obtained in A, all five
pZPB subfractions yielded comparable IC50 values after
co-incubation with pZPC.
|
|
The ability of pZPB1-pZPB3, but not
pZPB4 or pZPB5, to displace biotin-pZP(B+C)
implied that competitor activity depends upon the coordinate action of
pZPB and pZPC glycoproteins. To test this hypothesis, a fixed quantity
of pZPB5 was preincubated (4 °C, overnight) with
variable amounts of added pZPC and allowed to compete with
biotin-pZP(B+C) in the solid phase binding assay. Whereas pZPC added
alone did not block binding of biotin-pZP(B+C) to sperm membranes (Fig.
2C), co-incubates with pZPC:pZPB5 ratios of 1:5,
1:2, and 1:1 were excellent competitors (Fig. 2B).
Based on the above results, pZPB1-pZPB5 were
tested in the solid phase binding assay after overnight preincubation
with pZPC (pZPC:pZPB5 ratio = 1:2). In the presence of
added pZPC, all five pZPB subfractions produced similar competitive
binding curves (Fig. 2C); IC50 values
(n = 2) were 11.4 ± 1.6, 11.4 ± 1.4, 8.2 ± 1.1, 7.1 ± 0.3, and 6.5 ± 0.5 nM
for pZPB1-pZPB5, respectively. Taken together,
these results implied the existence of a membrane-associated zona-binding protein with high affinity binding sites for putative pZPB-pZPC complexes, but not individual pZPB or pZPC glycoproteins. Further molecular and functional studies of pZPB-pZPC interactions focused on pZPB5.
Purified pZPB5 Is Predominantly Monomeric--
We used
MALDI-MS and size exclusion chromatography to evaluate the oligomeric
status of purified pZPB5. The MALDI spectra of
pZPB5 (Fig. 3) and pZPB
starting material (not shown) were highly similar and indicated masses
centered about 43,643 and 43,577 Da for the constituent families of
pZPB glycoforms, respectively. However, in contrast to the complex
elution profile of pZPB starting material in Fig. 1A, size
exclusion chromatography of pZPB5 on the
G3000SWXL column in high-salt PBS yielded a dominant peak at Kav = 0.435 (Fig.
4A); the molecular size
relative to protein standards (Fig. 4B) was
Mr 55,400. As this approximates the molecular mass determined by MALDI-MS, pZPB5 most likely exists as
monomers in high-salt PBS. The presence of minor
Mr 124,000 and 230,000 peaks at
Kav = 0.313 and 0.221, respectively, indicated a
tendency of the pZPB glycoprotein to self-associate.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
MALDI mass spectrum of
pZPB5. The [M + H]+ peak indicates a
mass centered about 43,643 Da for the multiple pZPB glycoforms.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
pZPB5 elutes as a monomer during
size exclusion chromatography. A, after overnight
preincubation at 400 µg/ml in high-salt PBS, an 8-µg aliquot of
pZPB5 was injected onto a TSK G3000SWXL HPLC
column equilibrated with high-salt PBS mobile phase. The major peak had
a Mr 55,400 based on the calibration curve in
B. Protein standards in B included, in order of
elution, thyroglobulin (669 kDa), glutamate dehydrogenase (330 kDa),
human IgG (160 kDa), aldolase (158 kDa), lactate dehydrogenase (140 kDa), transferrin (80 kDa), ovalbumin (43 kDa), carbonic
anhydrase (29 kDa), soybean trypsin inhibitor (20.1 kDa), horse
myoglobin (17 kDa), and cytochrome c (12.4 kDa).
|
|
pZPB5 and pZPC Form Heteromultimeric
Complexes--
Size exclusion chromatography provided direct evidence
that co-incubated pZPB and pZPC glycoproteins form heterocomplexes. Proteins were incubated overnight at 4 °C in 40 µl of high-salt PBS as follows: (i), pZPB5, 16 µg; (ii),
pZPB5, 16 µg + fetuin, 12 µg; (iii), pZPB5,
16 µg + pZPC, 12 µg; (iv), pZPC, 12 µg; and (v), pZPC, 12 µg + fetuin, 16 µg. Fetuin, a glycoprotein with physicochemical
characteristics similar to pZPB and pZPC, served as a negative control.
Twenty-µl aliquots were injected onto the TSK G3000SWXL
HPLC column and 1-min fractions were collected. Elution of pZPB and
pZPC glycoproteins was monitored by Western blotting using
anti-pZPB319-330 and MA-451, respectively. When
preincubated alone (not shown) or with fetuin (Fig.
5A), the pZPB5
glycoprotein eluted as a monomer in fraction 17 (cross-reference, Fig.
4A). In contrast, the pZPC glycoprotein eluted as multiple peaks (Mr 300,000, Kav = 0.178; Mr 160,000, Kav = 0.274; Mr 68,000, Kav = 0.404) in fractions 14-17 whether preincubated alone (not shown) or in
the presence of fetuin (Fig. 5C); the
Mr 160,000 peak (fraction 15) was predominant.
Importantly, when pZPB5 and pZPC were co-incubated, the
chromatographic behavior of each changed dramatically (Fig. 5,
B and D); a major percentage of each glycoprotein now eluted in the void volume (fraction 11). The elution shifts demonstrate that when incubated together, pZPB and pZPC glycoproteins assemble into high mass heterocomplexes.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 5.
Co-incubated pZPB5 and pZPC form
heteromultimeric complexes. Co-incubations were performed
overnight at 4 °C in 40 µl of high-salt PBS: 16 µg of
pZPB5 + 12 µg of pZPC (B and D); 16 µg of pZPB5 + 12 µg of fetuin (A); 12 µg
of pZPC + 16 µg of fetuin (C). Samples were injected onto
a TSK G3000SWXL HPLC column via a 20-µl sample loop and
1-min fractions (0.5 ml) were collected during elution with
high-salt PBS. For immunoblot analysis, 8-µl aliquots of fractions
11-17 were separated under nonreducing conditions on 10% SDS gels,
transferred to nitrocellulose, and probed with anti-pZPB319-330 (A and B) or
MA-451 (C and D) to monitor elution of pZPB and
pZPC glycoproteins, respectively. When co-incubated, pZPB5
and pZPC assembled into high mass complexes that eluted in the column
void volume (fraction 11) (B and D). In contrast, elution profiles of pZPB5 and pZPC preincubated separately
(not shown) were similar to those obtained following co-incubation with
fetuin (A and C).
|
|
High Affinity Binding of Biotin-labeled pZPB5-pZPC
Heterocomplexes to Boar Sperm Membrane Vesicles--
To further test
specificity of membrane-associated zona-binding proteins for pZPB-pZPC
heterocomplexes and to estimate binding affinities, we performed direct
binding experiments using biotin-labeled heterocomplexes generated by
co-incubation of either biotin-pZPB5 + pZPC or
pZPB5 + biotin-pZPC. In the first set of experiments, a
fixed concentration (100 µg/ml) of biotin-pZPB5 was
preincubated (overnight, 4 °C) in high-salt PBS with or without
variable quantities of pZPC. Co-incubates were diluted to yield 0.2 µg/ml biotin-pZPB5 (5.4 nM) and incubated
with immobilized membrane vesicles. Binding of biotin-pZPB5
depended strongly upon prior incubation with pZPC. At
pZPC:biotin-pZPB5 ratios <0.3:1, binding of
biotin-pZPB5 was directly proportional to the concentration
of co-incubated pZPC (Fig.
6A). Binding of
pZPC:biotin-pZPB5 co-incubates with ratios >0.3:1
plateaued at a level 30-fold higher than that observed with the
biotin-pZPB5 incubated alone sample. Presumably, under these experimental conditions, pZPC co-incubated with
biotin-pZPB5 in ratios 0.3:1 maximizes recruitment of
biotin-pZPB5 into heterocomplexes recognized by
membrane-associated zona-binding proteins. Co-incubates with
pZPC:biotin-pZPB5 or fetuin:biotin-pZPB5 ratios
of 1:1 were used to construct saturation binding curves. As shown in
Fig. 6B, pZPC-(biotin·pZPB5) heterocomplexes
exhibited high affinity, saturable binding; the EC50 value
(n = 3) equaled 4.3 ± 0.6 nM when
calculated on the basis of biotin-pZPB5 concentration. High affinity binding was notably absent following co-incubation of biotin-pZPB5 with fetuin.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 6.
Reconstituted pZPB5-pZPC
complexes bind with high affinity to boar sperm membrane
vesicles. A and B, binding of complexes containing biotin-pZPB5. A, 0.5 µg of
biotin-pZPB5 was co-incubated (overnight, 4 °C) in 10 µl of high-salt PBS containing 0 1.0 µg of pZPC. Binding of
(biotin·pZPB5)-pZPC complexes to boar sperm membrane
vesicles was measured at a final concentration of 0.2 µg/ml
biotin-pZPB5 (5.4 nM). B, 1.5 µg
of biotin-pZPB5 was co-incubated (overnight, 4 °C) in 15 µl of high-salt PBS with either 1.5 µg of pZPC (circles)
or 1.5 µg of fetuin (triangles) and then incubated with
immobilized membrane vesicles at the indicated final
biotin-pZPB5 concentrations. Note the high affinity
(EC50 = 4.3 nM), saturation binding of
reconstituted (biotin·pZPB5)-pZPC complexes.
C and D, experiments using biotin-pZPC.
C, 1.0 µg of biotin-pZPC was titrated with 0-4.0 µg of
pZPB5 in 10 µl of high-salt PBS (overnight, 4 °C).
Binding of pZPB5-(biotin·pZPC) complexes to boar sperm membrane vesicles was measured at a final concentration of 0.1 µg/ml
biotin-pZPC (2.8 nM). D, 1.5 µg of biotin-pZPC
was co-incubated (overnight, 4 °C) in 15 µl of high-salt PBS with
either 3.0 µg of pZPB5 (circles) of 3.0 µg
of fetuin (triangles) and then incubated with immobilized
membranes at varying final concentrations of biotin-pZPC. Reconstituted
pZPB5-(biotin·pZPC) complexes exhibited high affinity
(EC50 = 1.7 nM), saturation binding comparable
to that observed with reconstituted (biotin·pZPB5)-pZPC complexes in
B.
|
|
Biotin-pZPC was unable to bind independently to membrane-associated
receptors. As shown in Fig. 6C, biotin-pZPC preincubated alone lacked ligand activity. pZPB5 added as a co-incubate
during the preincubation period promoted binding of biotin-pZPC with a
maximal response attained at pZPB5:biotin-pZPC ratios of
1.4:1. Consequently, co-incubates with pZPB5:biotin-pZPC
ratios of 2:1 were used to construct saturation binding curves (Fig.
6D). Nonlinear regression analysis of the binding isotherm
for pZPB5-(biotin·pZPC) heterocomplexes yielded an
EC50 value (n = 4) of 1.7 ± 0.1 nM calculated on the basis of biotin-pZPC concentration.
Binding was not detected following co-incubation of biotin-pZPC and
fetuin.
 |
DISCUSSION |
Using highly purified glycoproteins isolated from the pig oocyte
zona pellucida, we demonstrate for the first time that pZPB and pZPC
associate to form high mass heteromultimeric complexes. We also provide
the first description of a zona binding activity in boar sperm
membranes that possesses avid affinity for pZPB-pZPC heterocomplexes
but not the free zona glycoprotein subunits. As a consequence, we
propose that at least for the porcine system, pZPB-pZPC heteromers are
important functional and structural units of this gamete-specific
extracellular matrix.
Data presented earlier (22) suggested that pZPB binds directly to
isolated boar sperm membranes and hinted that pZPB can associate with
pZPC to form putative pZPB-pZPC complexes with enhanced binding
affinity. Our new data obtained with pZPB depleted of residual pZPC
contaminant by size exclusion chromatography confirm the heterotypic
association of co-incubated pZPB and pZPC glycoproteins but
conclusively demonstrate that free pZPB subunits fail to engage
membrane-associated zona-binding proteins. Consequently we conclude
that pZPB-pZPC complexes, although present in minor amounts, accounted
exclusively for the ligand activity observed for earlier pZPB
preparations (20, 22).
Size exclusion chromatography and Western blot analyses reveal that
co-incubated pZPB5 and pZPC assemble into high mass
heterocomplexes. Although the domains mediating this associative
interaction are not yet identified, pZPB residues 142-187 encompass a
cysteine-rich trefoil motif, or P-domain, which is expressed in mucins
and secretory peptides and is postulated to mediate protein-protein and
protein-carbohydrate interactions (28-30). In addition, pZPB (residues
190-454), pZPC (residues 45-306), and pZPA (residues 368-623) each
contain a single ZP domain (31) consisting of a module with eight
conserved cysteines and presumed characteristic three-dimensional
structure which has been suggested to mediate binding activities
between proteins that form filamentous extracellular matrices (32, 33). Native pig zona pellucida glycoproteins also possess N- and
O-linked oligosaccharides bearing sulfated polylactosamines
(34-36). As the pZPB and pZPC molecules have by necessity been exposed
to endo- -galactosidase during the purification protocol, we can conclude that the polylactosamines associated with native glycoproteins are not required for assembly of pZPB-pZPC heterocomplexes or subsequent high affinity binding to membrane vesicles. Congruently, enzymatic removal of polylactosamines does not diminish the biological activity of pZP(B+C) preparations in competitive sperm-zona adhesion assays (20). Polylactosamines nonetheless partially occlude a peptide
epitope on pZPB (37) and attenuate binding affinity of pZP(B+C) toward
membrane vesicles (22). By analogy, in the native zona pellucida these
highly extended and intensely anionic glycans may modulate
(a) subunit interactions that drive assembly and maintain
stability of pZPB-pZPC complexes and (b) affinity of
pZPB-pZPC complexes toward zona-binding proteins on boar sperm.
Experiments performed with reconstituted pZPB-pZPC complexes in which
one partner molecule bears a biotin label have permitted measurement of
ligand binding affinity and confirmed obligate specificity of
membrane-associated zona-binding proteins for pZPB-pZPC heteromers.
Based on saturation binding curves (Fig. 6), binding affinities for
(biotin·pZPB5)-pZPC complexes (EC50 = 4.3 nM) and pZPB5-(biotin·pZPC) complexes
(EC50 = 1.7 nM) are comparable. The somewhat
lower binding affinity of (biotin·pZPB5)-pZPC complexes may indicate an adverse affect of pZPB subunit biotinylation. Alternatively, the EC50 values may mirror the stoichiometry
of pZPB and pZPC subunits in membrane-binding heterocomplexes,
i.e. a pZPB:pZPC molar ratio of approximately 2-3:1.
Additional data support this hypothesis. Titration experiments
produced: (i) maximal receptor-binding activities at pZPB:pZPC molar
ratios of 3.3:1 for biotin-pZPB5 + pZPC co-incubates and
1.4:1 for pZPB5 + biotin-pZPC co-incubates (Fig. 6), and
(ii) optimal competitor activity at a pZPB:pZPC molar ratio of ~2:1
for pZPB5 + pZPC co-incubates (Fig. 2B). At
present, more direct attempts to define the minimal size and subunit
composition of heteromers capable of engaging membrane-associated
zona-binding proteins have been precluded by the avid propensity of
co-incubated pZPB and pZPC glycoproteins to assemble into high mass
heterocomplexes.
Work from other laboratories supports the hypothesis that pZPB and pZPC
are intimately associated within the native zona pellucida (38-40).
When particulate pig zonae are digested with boar sperm acrosin under
conditions where both suprastructure and sperm binding activity are
minimally affected, pZPA is selectively degraded and the corresponding
Mr 90,000 band is no longer detected on SDS
gels. Staining intensity of the Mr 55,000 band
is not affected indicating that the pZPB and pZPC glycoproteins resist
acrosin digestion in the intact zona. Consequently, protease-resistant pZPB-pZPC complexes likely form the main structural framework of the
pig zona matrix, whereas pZPA serves as a cross-linking molecule.
Whether ZPB-ZPC interactions contribute to zona architecture in other
species is as yet uncertain. In the mouse, protease-resistant filaments
comprised of ZP2 and ZP3 glycoproteins are interconnected via ZP1
cross-links to form a three-dimensional matrix (41). Although further
molecular details have not been reported, ZP1 must establish molecular
contact with ZP2 and/or ZP3 at cross-linkage sites. As the mouse ZP1,
ZP2, and ZP3 glycoproteins are encoded by the respective members of the
ZPB (42), ZPA (6), and ZPC (5) gene families, specific interactions
between ZPB and ZPC gene products, i.e. ZP1 and ZP3, may in
theory contribute to assembly and stability of the mouse zona
matrix.
Aside from a potential structural role within the pig zona pellucida,
pZPB-pZPC complexes function as high affinity ligands for cognate
zona-binding proteins present in isolated boar sperm membrane vesicles.
As neither subunit binds independently, our data define a ligand
distinct from others previously described in the sperm-zona literature.
Most notably, the mouse ZPC gene product, ZP3, acts independently as a
sperm-adhesive molecule and as a secretagogue for acrosomal exocytosis
(11, 43, 44). Moreover, kinetic analyses of binding of
125I-labeled acid-solubilized mouse zonae pellucidae to
glutaraldehyde-fixed mouse sperm suggest that ZP3 binds to receptor(s)
as a high affinity (Kd = 0.72 nM),
multivalent ligand (45). Thus the mouse and the pig employ contrasting
molecular mechanisms for constructing high affinity sperm-binding
sites, i.e. zona glycoproteins acting: (i) independently as
multivalent ligands (mouse: ZP3) or (ii) co-dependently as
hetero-oligomers (pig: pZPB and pZPC).
In the rabbit, two reports suggest participation of ZPB and ZPC gene
products in sperm-zona interactions. First, a recombinant ZPB-encoded
protein (BV55) binds to rabbit zonae and also elicits blocking
antibodies (46). Second, cross-linking and immunoprecipitation experiments (47) show that when incubated with heat-solubilized rabbit
zona pellucida, the recombinant rabbit sperm protein rSp17 binds
macromolecular complexes containing both the R55 (i.e. rZPB) (8) and R45 (i.e. rZPC) (13) zona proteins. Whether rSp17 has an obligate binding specificity for R55-R45 heteromers is an
intriguing question that remains unanswered.
The present study raises important questions regarding the mechanism by
which association of pZPB and pZPC glycoproteins creates a high
affinity ligand and whether one or both subunits in this complex
directly engage cognate zona-binding proteins. In one scenario, a
conformational change concomitant with hetero-oligomerization may
expose a cryptic adhesion domain in one subunit. Assuming that (i)
domains responsible for subunit interactions are conserved across
species and (ii) sperm adhesive determinants are species-specific, then
experiments that test binding of chimeric ZPB-ZPC complexes to boar
sperm membrane vesicles may provide insight into specificity of
corresponding zona-binding proteins. In this context, a preliminary experiment has shown that Chinese hamster ovary expressed recombinant human pZPC promotes binding of biotin-pZPB5 to boar sperm
membrane vesicles.3
Alternatively, pig sperm-zona interactions may mimic the gonadotropin ligand-receptor model (48) and both pZPB and pZPC may participate directly in binding, e.g. by creation of a high affinity
adhesion domain consisting of oligosaccharides and/or peptide residues contributed by both molecules.
Zona carbohydrates play an essential role in mammalian gamete
interactions (49), and several reports in the literature (18, 19, 23,
36, 50) provide evidence that the pig system conforms with this
paradigm. The current study, where we demonstrate that boar sperm
membranes exhibit an obligate specificity for heteromeric pZPB-pZPC
complexes, emphasizes that attempts to identify bioactive carbohydrate
ligands in the solid phase system by use of chemically or enzymatically
liberated pig zona glycans are likely to prove futile. Alternative
approaches, such as assembly of pZPB-pZPC complexes using either native
pig zona proteins pretreated with glycosidases or recombinant pig zona
proteins with foreign N- and O-glycans or ablated
glycosylation sequons, are therefore required. By analogy to the
gonadotropins (51), data from such experiments must be interpreted with
caution as molecular modifications that alter the interaction between
pZPB and pZPC subunits may in theory also diminish the avidity of
reconstituted pZPB-pZPC complexes for cognate zona-binding
proteins.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant HD23163 (to E. C. Y.). Matrix assisted laser
desorption/ionization mass spectrometry analysis was performed at the
Michigan State University Mass Spectrometry Facility, which is
supported in part by National Institutes of Health Grant RR00480 (to
D. A. G.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Wayne State University,
Dept. of Ob/Gyn, 275 East Hancock, Detroit, MI 48201. Tel.:
313-577-1228; Fax: 313-577-8554; E-mail: e.yurewicz{at}wayne.edu.
1
The abbreviations used are: HPLC, high
performance liquid chromatography; PBS, phosphate-buffered saline;
MALDI-MS, matrix-assisted laser desorption/ionization mass
spectrometry; TBS, Tris-buffered saline; BSA, bovine serum albumin;
MES, 2-(N-morpholino)ethane sulfonic acid.
2
E. C. Yurewicz, unpublished results.
3
E. C. Yurewicz and G. K. Fontenot,
unpublished results.
 |
REFERENCES |
-
Baba, T.,
Kashiwabara, S.,
Watanabe, K.,
Itoh, H.,
Michikawa, Y.,
Kimura, K.,
Takada, M.,
Fukamizu, A.,
and Arai, Y.
(1989)
J. Biol. Chem.
264,
11920-11927[Abstract/Free Full Text]
-
Bookbinder, L. H.,
Cheng, A.,
and Bleil, J. D.
(1995)
Science
269,
86-89[Abstract/Free Full Text]
-
Burks, D. J.,
Carballada, R.,
Moore, H. D. M.,
Saling, P. M.
(1995)
Science
269,
83-86[Abstract/Free Full Text]
-
Hardy, D. M.,
and Garbers, D. L.
(1995)
J. Biol. Chem.
270,
26025-26028[Abstract/Free Full Text]
-
Kinloch, R. A.,
Roller, R. J.,
Fimiani, C. M.,
Wassarman, D. A.,
Wassarman, P. M.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
6409-6413[Abstract/Free Full Text]
-
Liang, L.-F.,
Chamow, S. M.,
and Dean, J.
(1990)
Mol. Cell. Biol.
10,
1507-1515[Abstract/Free Full Text]
-
Sanz, L.,
Calvete, J. J.,
Mann, K.,
Schäfer, W.,
Schmid, E. R.,
Töpfer-Petersen, E.
(1992)
Eur. J. Biochem.
205,
645-652[Medline]
[Order article via Infotrieve]
-
Schwoebel, E.,
Prasad, S.,
Timmons, T. M.,
Cook, R.,
Kimura, H.,
Niu, E.-M.,
Cheung, P.,
Skinner, S.,
Avery, S. E.,
Wilkins, B.,
Dunbar, B. S.
(1991)
J. Biol. Chem.
266,
7214-7219[Abstract/Free Full Text]
-
Shur, B. D.,
and Neely, C. A.
(1988)
J. Biol. Chem.
263,
17706-17714[Abstract/Free Full Text]
-
Yurewicz, E. C.,
Hibler, D.,
Fontenot, G. K.,
Sacco, A. G.,
Harris, J.
(1993)
Biochim. Biophys. Acta
1174,
211-214[Medline]
[Order article via Infotrieve]
-
Zhu, X.,
and Naz, R. K.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
4704-4709[Abstract/Free Full Text]
-
Snell, W. J.,
and White, J. M.
(1996)
Cell
85,
629-637[CrossRef][Medline]
[Order article via Infotrieve]
-
Harris, J. D.,
Hibler, D. W.,
Fontenot, G. K.,
Hsu, K. T.,
Yurewicz, E. C.,
Sacco, A. G.
(1994)
DNA Sequence
4,
361-393[Medline]
[Order article via Infotrieve]
-
Taya, T.,
Yamasaki, N.,
Tsubamoto, H.,
Hasegawa, A.,
and Koyama, K.
(1995)
Biochem. Biophys. Res. Commun.
207,
790-799[CrossRef][Medline]
[Order article via Infotrieve]
-
Yurewicz, E. C.,
Sacco, A. G.,
and Subramanian, M. G.
(1983)
Biol. Reprod.
29,
511-523[Abstract]
-
Hedrick, J. L.,
and Wardrip, N. J.
(1986)
Anal. Biochem.
157,
63-70[CrossRef][Medline]
[Order article via Infotrieve]
-
Yurewicz, E. C.,
Sacco, A. G.,
and Subramanian, M. G.
(1987)
J. Biol. Chem.
262,
564-571[Abstract/Free Full Text]
-
Berger, T.,
Turner, K. O.,
Meizel, S.,
and Hedrick, J. L.
(1989)
Biol. Reprod.
40,
525-530[Abstract]
-
Berger, T.,
Davis, A.,
Wardrip, N. J.,
Hedrick, J. L.
(1989)
J. Reprod. Fertil.
86,
559-565[Abstract/Free Full Text]
-
Sacco, A. G.,
Yurewicz, E. C.,
Subramanian, M. G.,
Matzat, P. D.
(1989)
Biol. Reprod.
41,
523-532[Abstract]
-
Jones, R.
(1991)
Development
111,
1155-1163[Abstract/Free Full Text]
-
Yurewicz, E. C.,
Pack, B. A.,
Armant, D. R.,
Sacco, A. G.
(1993)
Mol. Reprod. Dev.
36,
382-389[CrossRef][Medline]
[Order article via Infotrieve]
-
Yonezawa, N.,
Aoki, H.,
Hatanaka, Y.,
and Nakano, M.
(1995)
Eur. J. Biochem.
233,
35-41[Medline]
[Order article via Infotrieve]
-
Hall, L.-L. H.,
Yurewicz, E. C.,
Sacco, A. G.,
Moghissi, K. S.
(1995)
J. Soc. Gynecol. Invest.
2,
552-558 [CrossRef][Medline]
[Order article via Infotrieve]
-
Gupta, S. K.,
Bagavant, H.,
Chadha, K.,
Gupta, M.,
Yurewicz, E. C.,
Sacco, A. G.
(1993)
Am. J. Reprod. Immunol.
30,
95-100
-
Afzalpurkar, A.,
and Gupta, S. K.
(1997)
Am. J. Reprod. Immunol.
38,
26-32
-
Gupta, S. K.,
Yurewicz, E. C.,
Afzalpurkar, A.,
Rao, K. V. S.,
Gage, D. A.,
Wu, H.,
Sacco, A. G.
(1995)
Mol. Reprod. Dev.
42,
220-225[CrossRef][Medline]
[Order article via Infotrieve]
-
Bork, P.
(1993)
Protein Sci.
2,
669-670[Medline]
[Order article via Infotrieve]
-
De, A.,
Brown, D. G.,
Gorman, M. A.,
Carr, M.,
Sanderson, M. R.,
Freemont, P. S.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
1084-1088[Abstract/Free Full Text]
-
Hoffman, W.,
and Hauser, F.
(1993)
Trends Biochem. Sci.
18,
239-243[CrossRef][Medline]
[Order article via Infotrieve]
-
Bork, P.,
and Sander, C.
(1992)
FEBS Lett.
300,
237-240[CrossRef][Medline]
[Order article via Infotrieve]
-
Killick, R.,
Legan, P. K.,
Malenczak, C.,
and Richardson, G. P.
(1995)
J. Cell Biol.
129,
535-547[Abstract/Free Full Text]
-
Legan, P. K.,
Rau, A.,
Keen, J. N.,
Richardson, G. P.
(1997)
J. Biol. Chem.
272,
8791-8801[Abstract/Free Full Text]
-
Hokke, C. H.,
Damm, J. B. L.,
Penninkhof, B.,
Aitken, R. J.,
Kamerling, J. P.,
Vliegenthart, J. F. G.
(1994)
Eur. J. Biochem.
221,
491-512[Medline]
[Order article via Infotrieve]
-
Noguchi, S.,
Hatanaka, Y.,
Tobita, T.,
and Nakano, M.
(1992)
Eur. J. Biochem.
204,
1089-1100[Medline]
[Order article via Infotrieve]
-
Yurewicz, E. C.,
Pack, B. A.,
and Sacco, A. G.
(1991)
Mol. Reprod. Dev.
30,
126-134[CrossRef][Medline]
[Order article via Infotrieve]
-
Yurewicz, E. C.,
Zhang, S.,
and Sacco, A. G.
(1993)
J. Reprod. Fertil.
98,
147-152[Abstract/Free Full Text]
-
Dunbar, B. S.,
and Bundman, D. S.
(1987)
J. Reprod. Fertil.
81,
363-376[Abstract/Free Full Text]
-
Dunbar, B. S.,
Dudkiewicz, A. B.,
and Bundman, D. S.
(1985)
Biol. Reprod.
32,
619-630[Abstract]
-
Urch, U. A.,
Wardrip, N. J.,
and Hedrick, J. L.
(1985)
J. Exp. Zool.
233,
479-483[CrossRef][Medline]
[Order article via Infotrieve]
-
Greve, J. M.,
and Wassarman, P. M.
(1985)
J. Mol. Biol.
181,
253-264[CrossRef][Medline]
[Order article via Infotrieve]
-
Epifano, O.,
Liang, L.,
and Dean, J.
(1995)
J. Biol. Chem.
270,
27254-27258[Abstract/Free Full Text]
-
Beebe, S. J.,
Leyton, L.,
Burks, D.,
Ishikawa, M.,
Fuerst, T.,
Dean, J.,
and Saling, P.
(1992)
Dev. Biol.
151,
48-54[CrossRef][Medline]
[Order article via Infotrieve]
-
Miller, D. J.,
Macek, M. B.,
and Shur, B. D.
(1992)
Nature
357,
589-593[CrossRef][Medline]
[Order article via Infotrieve]
-
Thaler, C. D.,
and Cardullo, R. A.
(1996)
J. Biol. Chem.
271,
23289-23297[Abstract/Free Full Text]
-
Prasad, S. V.,
Wilkins, B.,
Skinner, S. M.,
Dunbar, B. S.
(1996)
Mol. Reprod. Dev.
43,
519-529[CrossRef][Medline]
[Order article via Infotrieve]
-
Yamasaki, N.,
Richardson, R. T.,
and O'Rand, M. G.
(1995)
Mol. Reprod. Dev.
40,
48-55[CrossRef][Medline]
[Order article via Infotrieve]
-
Moyle, W. R.,
Campbell, R. K.,
Rao, S. N. V.,
Ayad, N. G.,
Bernard, M. P.,
Han, Y.,
Wang, Y.
(1995)
J. Biol. Chem.
270,
20020-20031[Abstract/Free Full Text]
-
Tulsiani, D. R. P.,
Yoshida-Komiya, H.,
and Araki, Y.
(1997)
Biol. Reprod.
57,
487-494[CrossRef][Medline]
[Order article via Infotrieve]
-
Dostálová, Z.,
Calvete, J. J.,
Sanz, L.,
and Töpfer-Petersen, E.
(1995)
Eur. J. Biochem.
230,
329-336[Medline]
[Order article via Infotrieve]
-
Cosowsky, L.,
Lin, W.,
Han, Y.,
Bernard, M. P.,
Campbell, R. K.,
Moyle, W. R.
(1997)
J. Biol. Chem.
272,
3309-3314[Abstract/Free Full Text]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Goudet, S. Mugnier, I. Callebaut, and P. Monget
Phylogenetic Analysis and Identification of Pseudogenes Reveal a Progressive Loss of Zona Pellucida Genes During Evolution of Vertebrates
Biol Reprod,
May 1, 2008;
78(5):
796 - 806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. van Gestel, I. A. Brewis, P. R. Ashton, J. F. Brouwers, and B. M. Gadella
Multiple proteins present in purified porcine sperm apical plasma membranes interact with the zona pellucida of the oocyte
Mol. Hum. Reprod.,
July 1, 2007;
13(7):
445 - 454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hasegawa, N. Kanazawa, H. Sawai, S. Komori, and K. Koyama
Pig zona pellucida 2 (pZP2) protein does not participate in zona pellucida formation in transgenic mice.
Reproduction,
September 1, 2006;
132(3):
455 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Caballero-Campo, M. Chirinos, X. J. Fan, M. E. Gonzalez-Gonzalez, M. Galicia-Chavarria, F. Larrea, and G. L. Gerton
Biological Effects of Recombinant Human Zona Pellucida Proteins on Sperm Function
Biol Reprod,
April 1, 2006;
74(4):
760 - 768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Yonezawa, K. Kudo, H. Terauchi, S. Kanai, N. Yoda, M. Tanokura, K. Ito, K.-i. Miura, T. Katsumata, and M. Nakano
Recombinant Porcine Zona Pellucida Glycoproteins Expressed in Sf9 Cells Bind to Bovine Sperm but Not to Porcine Sperm
J. Biol. Chem.,
May 27, 2005;
280(21):
20189 - 20196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. von Witzendorff, M. Ekhlasi-Hundrieser, Z. Dostalova, M. Resch, D. Rath, H.-W. Michelmann, and E. Topfer-Petersen
Analysis of N-linked glycans of porcine zona pellucida glycoprotein ZPA by MALDI-TOF MS: a contribution to understanding zona pellucida structure
Glycobiology,
May 1, 2005;
15(5):
475 - 488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chakravarty, K. Suraj, and S. K. Gupta
Baculovirus-expressed recombinant human zona pellucida glycoprotein-B induces acrosomal exocytosis in capacitated spermatozoa in addition to zona pellucida glycoprotein-C
Mol. Hum. Reprod.,
May 1, 2005;
11(5):
365 - 372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.J. Conner, L. Lefievre, D.C. Hughes, and C.L.R. Barratt
Cracking the egg: increased complexity in the zona pellucida
Hum. Reprod.,
May 1, 2005;
20(5):
1148 - 1152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bausek, H. H. Ruckenbauer, S. Pfeifer, W. J. Schneider, and F. Wohlrab
Interaction of Sperm with Purified Native Chicken ZP1 and ZPC Proteins
Biol Reprod,
August 1, 2004;
71(2):
684 - 690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Lefievre, S.J. Conner, A. Salpekar, O. Olufowobi, P. Ashton, B. Pavlovic, W. Lenton, M. Afnan, I.A. Brewis, M. Monk, et al.
Four zona pellucida glycoproteins are expressed in the human
Hum. Reprod.,
July 1, 2004;
19(7):
1580 - 1586.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Vo, T.-Y. Yen, B. A. Macher, and J. L. Hedrick
Identification of the ZPC Oligosaccharide Ligand Involved in Sperm Binding and the Glycan Structures of Xenopus laevis Vitelline Envelope Glycoproteins
Biol Reprod,
December 1, 2003;
69(6):
1822 - 1830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hemachand, B. Gopalakrishnan, D. M. Salunke, S. M. Totey, and C. Shaha
Sperm plasma-membrane-associated glutathione S-transferases as gamete recognition molecules
J. Cell Sci.,
May 15, 2002;
115(10):
2053 - 2065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Miller, X. Shi, and H. Burkin
Molecular Basis of Mammalian Gamete Binding
Recent Prog. Horm. Res.,
January 1, 2002;
57(1):
37 - 73.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Baker, R. A. Cardullo, and C. D. Thaler
Sonication of Mouse Sperm Membranes Reveals Distinct Protein Domains
Biol Reprod,
January 1, 2002;
66(1):
57 - 64.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. D. Thaler and R. A. Cardullo
Distinct Membrane Fractions from Mouse Sperm Bind Different Zona Pellucida Glycoproteins
Biol Reprod,
January 1, 2002;
66(1):
65 - 69.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. S. Dunbar, T. M. Timmons, S. M. Skinner, and S. V. Prasad
Molecular Analysis of a Carbohydrate Antigen Involved in the Structure and Function of Zona Pellucida Glycoproteins
Biol Reprod,
September 1, 2001;
65(3):
951 - 960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Govind, G. K. Gahlay, S. Choudhury, and S. K. Gupta
Purified and Refolded Recombinant Bonnet Monkey (Macaca radiata) Zona Pellucida Glycoprotein-B Expressed in Escherichia coli Binds to Spermatozoa
Biol Reprod,
April 1, 2001;
64(4):
1147 - 1152.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. K. Govind, A. Hasegawa, K. Koyama, and S. K. Gupta
Delineation of a Conserved B Cell Epitope on Bonnet Monkey (Macaca radiata) and Human Zona Pellucida Glycoprotein-B by Monoclonal Antibodies Demonstrating Inhibition of Sperm-Egg Binding
Biol Reprod,
January 1, 2000;
62(1):
67 - 75.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T Rankin, P Talbot, E Lee, and J Dean
Abnormal zonae pellucidae in mice lacking ZP1 result in early embryonic loss
Development,
January 9, 1999;
126(17):
3847 - 3855.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Rankin, Z. Tong, P. Castle, E Lee, R Gore-Langton, L. Nelson, and J Dean
Human ZP3 restores fertility in Zp3 null mice without affecting order-specific sperm binding
Development,
January 7, 1998;
125(13):
2415 - 2424.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bausek, M. Waclawek, W. J. Schneider, and F. Wohlrab
The Major Chicken Egg Envelope Protein ZP1 Is Different from ZPB and Is Synthesized in the Liver
J. Biol. Chem.,
September 8, 2000;
275(37):
28866 - 28872.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|